Filing Details
- Accession Number:
- 0001288123-10-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-11 12:00:00
- Reporting Period:
- 2010-03-10
- Filing Date:
- 2010-03-11
- Accepted Time:
- 2010-03-11 15:33:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1098972 | Antigenics Inc | AGEN | Biological Products, (No Disgnostic Substances) (2836) | 061562417 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
935679 | H Garo Armen | 162 Fifth Avenue Suite 900 New York NY 10010 | Chairman & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-03-10 | 231,579 | $0.77 | 1,683,483 | No | 4 | A | Direct | |
Common Stock | Disposition | 2010-03-11 | 87,628 | $0.79 | 1,595,855 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 12,655,941 | Indirect | by Antigenics Holdings LLC and Armen Partners |
Footnotes
- Represents settlement of restricted stock granted on March 10, 2010 in lieu of an annual cash bonus for 2009 performance.
- Represents only shares sold to cover minimum federal, state and local tax withholding requirements upon the vesting of the restricted shares granted in lieu of an annual cash bonus for 2009 performance.
- Dr. Armen is the General Partner of Armen Partners LP. As of the date of this report Armen Partners owns a total of 1,507,667 shares of Antigenics Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Armen Partners and disclaims beneficial ownership except to the extent of his pecuniary interest therein. Dr. Armen is also CEO, Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which, as of the date of this report, owns 11,154,274 shares of Antigenics Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims benficial ownership except to the extent of his pecuniary interest therein.